Skip to main content

Table 2 Patient characteristics

From: Comparison of two polysulfone membranes for continuous renal replacement therapy for sepsis: a prospective cross-over study

  Total (n = 8) SHG → AEF (n = 4) AEF → SHG (n = 4)
Age, median (IQR), years 80 (76–81) 80 (78–83) 78 (74–81)
Gender, male (number, %) 7 (87.5%) 3 (75%) 4 (100%)
Height, median (IQR), cm 167 (153–170) 167 (149–172) 166 (153–170)
Weight, median (IQR), kg 56 (46–71) 51 (44–58) 65 (48–82)
Body mass index, median (IQR), kg/m2 20.5 (15.1–25.6) 17.1 (14.4–20.9) 25.2 (19.1–28.5)
Source of sepsis, n, (%)
 Intrathoracic 2 (25%) 1 (25%) 1 (25%)
 Intraabdominal 4 (50%) 3 (75%) 1 (25%)
 Urogenital 1 (25%) 0 (0%) 1 (25%)
 Skin/soft tissue/bone/joint 1 (25%) 0 (0%) 1 (25%)
 APACHE II score, median (IQR) 21 (16–26) 23 (14–28) 19 (16–25)
 SOFA score, median (IQR) 11 (9–13) 12 (10–14) 10 (8–13)
 ICU stay, median (IQR), day 4.5 (4.0–27.8) 7 (4.3–30.8) 4.0 (4.0–26.5)
 Hospital mortality, n, (%) 5 (62.5%) 3 (75%) 2 (50%)
 Acute kidney injury, n, (%) 3 (37.5%) 1 (25%) 2 (50%)
 Lactate, median (IQR), mg/dL 34.7 (19.0–65.7) 45.7 (27.3–65.7) 22.0 (15.0–181.1)
 Procalcitonin, median (IQR), ng/mL 5.2 (3.8–17.2) 12.8 (4.8–46.7) 4.2 (1.5–8.3)
 Glasgow Coma Scale, median (IQR) 13 (6–15) 10 (4–15) 14 (8–15)
 Noradrenaline, median (IQR), μg/kg/min 0.3 (0.2–0.35) 0.28 (0.20–0.47) 0.30 (0.11–0.4)
  1. Data are presented as median (IQR) or n (%)
  2. APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, ICU intensive care unit, IQR interquartile range